GlassScriptPhysician profile
Osvaldo A Camilo
NPI 1902829898
$316.57
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $43.07 · 2021: $30.94 · 2022: $20.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $61.57 | 2019-2020 | |
| Microvention, INC. | $51.34 | 2019 | |
| Portola Pharmaceuticals, LLC | $51.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.94 | 2021 | |
| Medtronic Vascular, INC. | $21.70 | 2019 | |
| Imperative Care, INC | $20.55 | 2022 | |
| Medtronic USA, INC. | $19.37 | 2019 | |
| Greenwich Biosciences, INC. | $17.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.66 | 2019 | |
| Ge Healthcare | $14.54 | 2020 | |
| Kyowa Kirin, INC. | $13.50 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osvaldo Camilo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.